150 related articles for article (PubMed ID: 37002660)
1. SARM1-Dependent Axon Degeneration: Nucleotide Signaling, Neurodegenerative Disorders, Toxicity, and Therapeutic Opportunities.
McGuinness HY; Gu W; Shi Y; Kobe B; Ve T
Neuroscientist; 2023 Mar; ():10738584231162508. PubMed ID: 37002660
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.
Sasaki Y; Zhu J; Shi Y; Gu W; Kobe B; Ve T; DiAntonio A; Milbrandt J
Exp Neurol; 2021 Nov; 345():113842. PubMed ID: 34403688
[TBL] [Abstract][Full Text] [Related]
3. A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate Immunity.
Hopkins EL; Gu W; Kobe B; Coleman MP
Front Mol Biosci; 2021; 8():703532. PubMed ID: 34307460
[TBL] [Abstract][Full Text] [Related]
4. SARM1 is a metabolic sensor activated by an increased NMN/NAD
Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
[TBL] [Abstract][Full Text] [Related]
5. NAD
Alexandris AS; Koliatsos VE
Antioxid Redox Signal; 2023 Dec; 39(16-18):1167-1184. PubMed ID: 37503611
[No Abstract] [Full Text] [Related]
6. The NAD
Llobet Rosell A; Paglione M; Gilley J; Kocia M; Perillo G; Gasparrini M; Cialabrini L; Raffaelli N; Angeletti C; Orsomando G; Wu PH; Coleman MP; Loreto A; Neukomm LJ
Elife; 2022 Dec; 11():. PubMed ID: 36476387
[TBL] [Abstract][Full Text] [Related]
7. The SARM1 axon degeneration pathway: control of the NAD
Figley MD; DiAntonio A
Curr Opin Neurobiol; 2020 Aug; 63():59-66. PubMed ID: 32311648
[TBL] [Abstract][Full Text] [Related]
8. The chemical biology of NAD
Icso JD; Thompson PR
Curr Opin Chem Biol; 2022 Aug; 69():102176. PubMed ID: 35780654
[TBL] [Abstract][Full Text] [Related]
9. NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo.
Di Stefano M; Loreto A; Orsomando G; Mori V; Zamporlini F; Hulse RP; Webster J; Donaldson LF; Gering M; Raffaelli N; Coleman MP; Gilley J; Conforti L
Curr Biol; 2017 Mar; 27(6):784-794. PubMed ID: 28262487
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons.
Alexandris AS; Ryu J; Rajbhandari L; Harlan R; McKenney J; Wang Y; Aja S; Graham D; Venkatesan A; Koliatsos VE
Neurobiol Dis; 2022 Sep; 171():105808. PubMed ID: 35779777
[TBL] [Abstract][Full Text] [Related]
11. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
[TBL] [Abstract][Full Text] [Related]
12. SARM1 is required in human derived sensory neurons for injury-induced and neurotoxic axon degeneration.
Chen YH; Sasaki Y; DiAntonio A; Milbrandt J
Exp Neurol; 2021 May; 339():113636. PubMed ID: 33548217
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
[TBL] [Abstract][Full Text] [Related]
14. Deregulated mitochondrial quality control, the heel of Achilles in elucidating the role of autophagy in SARM1-mediated axon degeneration.
Wang S; Zhang Y; Song M; Zhao X; Song F
J Neurosci Res; 2024 Jan; 102(1):e25292. PubMed ID: 38284842
[TBL] [Abstract][Full Text] [Related]
15. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2.
Walker LJ; Summers DW; Sasaki Y; Brace EJ; Milbrandt J; DiAntonio A
Elife; 2017 Jan; 6():. PubMed ID: 28095293
[TBL] [Abstract][Full Text] [Related]
16. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
Gilley J; Orsomando G; Nascimento-Ferreira I; Coleman MP
Cell Rep; 2015 Mar; 10(12):1974-81. PubMed ID: 25818290
[TBL] [Abstract][Full Text] [Related]
17. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.
Ko KW; Milbrandt J; DiAntonio A
J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32609299
[TBL] [Abstract][Full Text] [Related]
18. NMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapies.
Loreto A; Antoniou C; Merlini E; Gilley J; Coleman MP
Neurosci Res; 2023 Dec; 197():18-24. PubMed ID: 36657725
[TBL] [Abstract][Full Text] [Related]
19. Natural variants of human SARM1 cause both intrinsic and dominant loss-of-function influencing axon survival.
Ademi M; Yang X; Coleman MP; Gilley J
Sci Rep; 2022 Aug; 12(1):13846. PubMed ID: 35974060
[TBL] [Abstract][Full Text] [Related]
20. An NAD+/NMN balancing act by SARM1 and NMNAT2 controls axonal degeneration.
Waller TJ; Collins CA
Neuron; 2021 Apr; 109(7):1067-1069. PubMed ID: 33831359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]